MedPath

Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer

Not Applicable
Withdrawn
Conditions
Mastectomy
Breast Reconstruction
Interventions
Procedure: Autologous Breast Reconstruction
Procedure: Breast Reconstruction with Artificial Implant
Procedure: Neurotization
Registration Number
NCT03135392
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

Tissue Expander/Implant Reconstruction: The purpose of this study is to determine how and when nerve sensation to the breast skin returns after mastectomy.

Autologous Tissue Reconstruction: The purpose of this study is to determine whether the tissue being used to reconstruct your breast can provide sensation by using your own nerves. Typically all sensation is lost immediately after this type of surgery and returns to varying degrees. We are hoping to demonstrate that by connecting the two nerves (one from abdomen and one from the chest wall) together, we can attain meaningful sensation in the transferred tissues thereby improving your quality of life following surgery.

Detailed Description

To determine the timing and distribution of sensation recovery of breast after mastectomy and breast reconstruction, both with autologous and implant-based reconstruction. Also, to determine the role of innervated free tissue transfer in breast reconstruction.

Specific Aims

1. Determine the timing and degree of return of breast in women who underwent mastectomy with autologous tissue or with implant based reconstruction.

2. Determine sensation following neurotized free flap reconstruction

3. Determine whether neurotization has an impact on quality of life measures post operatively

Study Design Patients will be enrolled prospectively in this data collection study in which they will receive the standard of care for breast cancer resection and oncologically safe and accepted means of breast reconstruction with tissue expander and/or prosthetic implants. Patients will receive additional, non-invasive sensory testing, performed at standard follow up intervals in clinic by their reconstructive team. All patients participating in the study will be consented for enrollment at the pre-operative visit by either the surgeon or physician assistant. As this is a prospective study, all women fitting inclusion criteria over a 6-month minimal, but projected goal 12-month period will be included.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Patients undergoing unilateral or bilateral skin sparing mastectomy for breast cancer

  • Patient must have one of the following reconstructions in planned:

    • Immediate tissue expander placement
    • Immediate implant placement
    • Immediate autologous breast reconstruction
  • All patients participating in the study must be willing to be consented for enrollment at the pre-operative visit.

Exclusion Criteria
  • Pre-operative radiation therapy
  • Any pre-excising
  • Patients with absent or prior damaged nipple areola-complex (NAC) on the "non-surgical breast"

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Autologous Breast Reconstruction without NeurotizationAutologous Breast ReconstructionParticipants undergoing autologous tissue (her own tissue from other areas of the body) reconstruction which do not have their nerves reconstructed during surgery
Autologous Breast Reconstruction with NeurotizationAutologous Breast ReconstructionParticipants undergoing autologous tissue (her own tissue from other areas of the body) reconstruction which have a nerve connected (neurotized) during surgery.
Autologous Breast Reconstruction with NeurotizationNeurotizationParticipants undergoing autologous tissue (her own tissue from other areas of the body) reconstruction which have a nerve connected (neurotized) during surgery.
Breast Reconstruction with Artificial ImplantBreast Reconstruction with Artificial ImplantParticipants undergoing unilateral reconstruction: patient will serve as internal control with contralateral breast and reconstructed breast will be compared to all other reconstructed breasts. Participants undergoing bilateral reconstruction: reconstructed breasts will be compared to all other reconstructed breasts
Primary Outcome Measures
NameTimeMethod
Composite measure of sensationUp to 24 months after surgery

Differences of at least 20% comparing control to experimental breasts would be clinically meaningful. Composite measure will be calculated by combining the follow binomial factors: detection of temperature difference (feeling hot and cold), detection of sharp versus dull pressure, detection of vibration, discerning point pressure

Secondary Outcome Measures
NameTimeMethod
Quality of Life as measured by a 19-question survey regarding sensation and appearance of breast.Up to 24 months after surgery

A total of 19 Likert scale questions will be given to participants in the pre- and post-Surgical Sensation Questionnaire regarding sensation and appearance of breast before and after reconstruction.

Trial Locations

Locations (1)

Cleveland Clinic, Case Comprehensive Cancer Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath